Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 630

1.

The second to fourth digit ratio in patients with congenital IGF-1 Deficiency.

Uchitel Y, Kauli R, Konen O, Lilos P, Laron Z.

Anthropol Anz. 2019 Feb 28. doi: 10.1127/anthranz/2019/0960. [Epub ahead of print]

PMID:
30816406
2.

Prevalence of diabetes among children treated with growth hormone in Israel.

Lutski M, Zucker I, Zadik Z, Libruder C, Blumenfeld O, Shohat T, Laron Z.

Diabet Med. 2019 Jan 28. doi: 10.1111/dme.13910. [Epub ahead of print]

PMID:
30690790
3.

The Era of Cadaveric Pituitary Extracted Human Growth Hormone (1958-1985):Biological and Clinical Aspects.

Laron Z.

Pediatr Endocrinol Rev. 2018 Sep;16(Suppl 1):11-16. doi: 10.17458/per.vol16.2018.la.hghcadavericpituitary.

PMID:
30378778
4.

Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action.

Aizen D, Pasmanik-Chor M, Sarfstein R, Laron Z, Bruchim I, Werner H.

Front Endocrinol (Lausanne). 2018 Mar 20;9:105. doi: 10.3389/fendo.2018.00105. eCollection 2018.

5.

A Novel Variant c.97C>T of the Growth Hormone Releasing Hormone Receptor Gene Causes Isolated Growth Hormone Deficiency Type Ib

Galli-Tsinopoulou A, Kotanidou EP, Kleisarchaki AN, Kauli R, Laron Z.

J Clin Res Pediatr Endocrinol. 2018 Jul 31;10(3):284-288. doi: 10.4274/jcrpe.5188. Epub 2018 Feb 28.

6.

Prolactin - Not Only a "Milk Hormone" Prolactin - Growth Hormone Relationships with Emphasis on Cancer.

Farfel A, Werner H, Laron Z.

Pediatr Endocrinol Rev. 2018 Mar;15(3):216-222. doi: 10.17458/per.vol15.2018.fwl.prolactinrelationshipscancer.

PMID:
29493126
7.

Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action.

Nagaraj K, Lapkina-Gendler L, Sarfstein R, Gurwitz D, Pasmanik-Chor M, Laron Z, Yakar S, Werner H.

Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1045-1050. doi: 10.1073/pnas.1715930115. Epub 2018 Jan 16.

8.

Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence.

Somri L, Sarfstein R, Lapkina-Gendler L, Nagaraj K, Laron Z, Bach LA, Werner H.

Growth Horm IGF Res. 2018 Apr;39:6-12. doi: 10.1016/j.ghir.2017.11.004. Epub 2017 Nov 24.

PMID:
29208357
9.

The relationship between serum levels of prolactin and growth hormone in the early postnatal period.

Daliot J, Laron-Kenet T, Wattad M, Ben-Dor A, Lilos P, Laron Z.

Pediatr Res. 2017 Nov;82(5):796-800. doi: 10.1038/pr.2017.164. Epub 2017 Aug 2.

PMID:
28700563
10.

IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome.

Laron Z, Kauli R, Lapkina L, Werner H.

Mutat Res Rev Mutat Res. 2017 Apr - Jun;772:123-133. doi: 10.1016/j.mrrev.2016.08.002. Epub 2016 Aug 5. Review.

PMID:
28528685
11.

Risk of Overweight in Adolescence among Offspring of Diabetic Mothers.

Farfel A, Merdler-Rabinowicz R, Abebe-Campino G, Derazne E, Laron-Kenet T, Laron Z.

Isr Med Assoc J. 2017 May;19(5):275-276. No abstract available.

12.

Genetic Mutations, Birth Lengths, Weights and Head Circumferences of Children with IGF-I Receptor Defects. Comparison with other Congenital Defects in the GH/IGF-I axis.

Essakow JL, Lauterpacht A, Lilos P, Kauli R, Laron Z.

Pediatr Endocrinol Rev. 2016 Sep;14(1):19-26. doi: 10.17458/PER.2016.ELLKL.GeneticMutations. Review.

PMID:
28508613
13.

For Debate: Growth Hormone Treatment of Infants Born Small for Gestational Age should be Started at or before the First Year of Age.

Laron Z, Laron-Kenet T, Klinger G.

Pediatr Endocrinol Rev. 2016 Dec;14(2):105-108. doi: 10.17458/PER.2016.LLK.FD.Growthhormonetreatment.

PMID:
28508604
14.

Fifty years on: New lessons from Laron syndrome.

Werner H, Lapkina-Gendler L, Laron Z.

Isr Med Assoc J. 2017 Jan;19(1):6-7. No abstract available.

15.

Mortality and cancer incidence among patients treated with recombinant growth hormone during childhood in Israel.

Libruder C, Blumenfeld O, Dichtiar R, Laron Z, Zadik Z, Shohat T, Afek A.

Clin Endocrinol (Oxf). 2016 Nov;85(5):813-818. doi: 10.1111/cen.13131. Epub 2016 Jul 20.

PMID:
27292870
16.

Identification of signaling pathways associated with cancer protection in Laron syndrome.

Lapkina-Gendler L, Rotem I, Pasmanik-Chor M, Gurwitz D, Sarfstein R, Laron Z, Werner H.

Endocr Relat Cancer. 2016 May;23(5):399-410. doi: 10.1530/ERC-16-0054. Epub 2016 Apr 18.

PMID:
27090428
17.

Growth, development, puberty and adult height of patients with congenital multiple pituitary hormone deficiencies.

Haim-Pinhas H, Kauli R, Lilos P, Laron Z.

Growth Horm IGF Res. 2016 Apr;27:46-52. doi: 10.1016/j.ghir.2016.01.004. Epub 2016 Feb 19.

PMID:
26947989
18.

Bone Age Estimation for Whom by Whom? By Which Method?

Laron Z.

Pediatr Endocrinol Rev. 2015 Sep;13(1):444-7.

PMID:
26540759
19.

Message from the Editors.

Laron Z, Geffner ME, Tanaka T.

Pediatr Endocrinol Rev. 2015 Sep;13(1):438. No abstract available.

PMID:
26540756
20.

LESSONS FROM 50 YEARS OF STUDY OF LARON SYNDROME.

Laron Z.

Endocr Pract. 2015 Dec;21(12):1395-402. doi: 10.4158/EP15939.RA. Epub 2015 Sep 24. Review.

PMID:
26401581
21.

Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients-From discovery to treatment.

Laron Z, Kauli R.

Growth Horm IGF Res. 2016 Jun;28:53-6. doi: 10.1016/j.ghir.2015.08.004. Epub 2015 Aug 18.

PMID:
26307357
22.

Epilogue: The future of Laron syndrome - The need for changes.

Laron Z.

Growth Horm IGF Res. 2016 Jun;28:79-80. doi: 10.1016/j.ghir.2015.07.007. Epub 2015 Jul 30. No abstract available.

PMID:
26283274
23.

Growth, development, puberty and adult height before and during treatment in children with congenital isolated growth hormone deficiency.

Smuel K, Kauli R, Lilos P, Laron Z.

Growth Horm IGF Res. 2015 Aug;25(4):182-8. doi: 10.1016/j.ghir.2015.05.001. Epub 2015 May 12.

PMID:
26077773
24.

The urgent need to prevent type 1 autoimmune childhood diabetes.

Laron Z, Hampe CS, Shulman LM.

Pediatr Endocrinol Rev. 2015 Mar;12(3):266-82. Review.

PMID:
25962204
25.

Insulin analogues display atypical differentiative activities in skin keratinocytes.

Solomon Zemler R, Weingarten G, Sarfstein R, Laron Z, Werner H, Wertheimer E.

Arch Physiol Biochem. 2015 Feb;121(1):32-9. doi: 10.3109/13813455.2014.1001856. Epub 2015 Apr 21.

PMID:
25897878
26.

Proliferative and signaling activities of insulin analogues in endometrial cancer cells.

Aizen D, Sarfstein R, Bruchim I, Weinstein D, Laron Z, Werner H.

Mol Cell Endocrinol. 2015 May 5;406:27-39. doi: 10.1016/j.mce.2015.02.011. Epub 2015 Feb 16.

PMID:
25697343
27.

Seasonality of birth of patients with juvenile idiopathic arthritis.

Berkun Y, Lewy H, Padeh S, Laron Z.

Clin Exp Rheumatol. 2015 Jan-Feb;33(1):122-6. Epub 2015 Jan 8.

PMID:
25571969
28.

Congenital hyperinsulinism, neonatal diabetes and the risk of malignancies: an international collaborative study. Preliminary communication.

Makov M, Chodick G, Mohnike K, Otonkoski T, Huopio H, Banerjee I, Cave H, Polak M, Christesen HT, Hussain K, Deleon D, Stanley C, Cappa M, Ramos O, Zangen D, Laron Z.

Diabet Med. 2015 May;32(5):701-3. doi: 10.1111/dme.12670. No abstract available.

PMID:
25494966
29.

Editor's commentary: sex hormone priming.

Laron Z.

Pediatr Endocrinol Rev. 2014 Mar;11(3):288. No abstract available.

PMID:
24716394
30.

The E180splice mutation in the GHR gene causing Laron syndrome: witness of a Sephardic Jewish exodus from the Iberian Peninsula to the New World?

Gonçalves FT, Fridman C, Pinto EM, Guevara-Aguirre J, Shevah O, Rosembloom AL, Hwa V, Cassorla F, Rosenfeld RG, Lins TS, Damiani D, Arnhold IJ, Laron Z, Jorge AA.

Am J Med Genet A. 2014 May;164A(5):1204-8. doi: 10.1002/ajmg.a.36444. Epub 2014 Mar 24.

PMID:
24664892
31.

Biphasic response of subscapular skinfold thickness to hGH or IGF-1 administration to patients with congenital IGHD, congenital MPHD and Laron syndrome.

Bisker-Kassif O, Kauli R, Lilos P, Laron Z.

Obes Res Clin Pract. 2014 Jan-Feb;8(1):e55-62. doi: 10.1016/j.orcp.2012.11.001.

PMID:
24548577
32.

Antibodies to islet cell autoantigens, rotaviruses and/or enteroviruses in cord blood and healthy mothers in relation to the 2010-2011 winter viral seasons in Israel: a pilot study.

Shulman LM, Hampe CS, Ben-Haroush A, Perepliotchikov Y, Vaziri-Sani F, Israel S, Miller K, Bin H, Kaplan B, Laron Z.

Diabet Med. 2014 Jun;31(6):681-5. doi: 10.1111/dme.12404. Epub 2014 Feb 25.

33.

Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer cells.

Weinstein D, Sarfstein R, Laron Z, Werner H.

Endocr Connect. 2014 Jan 28;3(1):24-35. doi: 10.1530/EC-13-0086. Print 2014.

34.

Letter to the Editor - responses to Weisntein D, Simon M, Yehezkel E, Laron Z, Werner H. Insulin analogues display IGF-I-like mitogenic and antiactivity in cultured cancer cells.

Weinstein D, Simon M, Yehezkel E, Laron Z, Werner H.

Diabetes Metab Res Rev. 2013 Aug 20. doi: 10.1002/dmrr.2447. [Epub ahead of print]

PMID:
23963859
36.

To be or not to be "TALL"?

Laron Z.

Pediatr Endocrinol Rev. 2012 Aug;9(4):696-7.

PMID:
23304805
37.

Differential effects of hGH and IGF-I on body proportions.

Laron Z, Silbergeld A, Kauli R.

Anthropol Anz. 2012 Jul;69(3):255-9.

PMID:
22928349
38.

From the Paediatric Endocrinology Club to the European Society for Paediatric Endocrinology: the early years of ESPE.

Illig R, Laron Z, Visser HK.

Pediatr Endocrinol Rev. 2011 Sep;9(1):417-21. Review.

PMID:
22783639
39.

Anthropometric indices of adolescents who at birth were full-term long and/or overweight for gestational age.

Farfel A, Derazne E, Tzur D, Linder N, Laron Z.

Isr Med Assoc J. 2012 Feb;14(2):93-5.

40.

Head circumference in untreated and IGF-I treated patients with Laron syndrome: comparison with untreated and hGH-treated children with isolated growth hormone deficiency.

Laron Z, Iluz M, Kauli R.

Growth Horm IGF Res. 2012 Apr;22(2):49-52. doi: 10.1016/j.ghir.2012.02.005. Epub 2012 Mar 11. Review.

PMID:
22414926
41.

The growth hormone-prolactin relationship: a neglected issue.

Laron Z.

Pediatr Endocrinol Rev. 2011 Dec;9(2):546-8. Review.

PMID:
22397138
42.

Growth hormone therapy: emerging dilemmas.

Laron Z.

Pediatr Endocrinol Rev. 2011 Jun;8(4):364-73. Review. Erratum in: Pediatr Endocrinol Rev. 2011 Sep;9(1):440.

PMID:
21972776
43.

The globe and orbit in Laron syndrome.

Kornreich L, Konen O, Lilos P, Laron Z.

AJNR Am J Neuroradiol. 2011 Sep;32(8):1560-2. doi: 10.3174/ajnr.A2573. Epub 2011 Jul 14.

44.

Cochlear hearing loss in patients with Laron syndrome.

Attias J, Zarchi O, Nageris BI, Laron Z.

Eur Arch Otorhinolaryngol. 2012 Feb;269(2):461-6. doi: 10.1007/s00405-011-1668-x. Epub 2011 Jul 8.

PMID:
21735352
45.

Possible link between month of birth and childhood leukemia supports the hypothesis of an infectious etiology.

Yaniv I, Lewy H, Avrahami G, Jeison M, Stark B, Laron Z.

Isr Med Assoc J. 2010 Dec;12(12):776. No abstract available.

46.

Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies.

Steuerman R, Shevah O, Laron Z.

Eur J Endocrinol. 2011 Apr;164(4):485-9. doi: 10.1530/EJE-10-0859. Epub 2011 Feb 3.

PMID:
21292919
47.

Controversies in the use of insulin analogues.

Werner H, Weinstein D, Yehezkel E, Laron Z.

Expert Opin Biol Ther. 2011 Feb;11(2):199-209. doi: 10.1517/14712598.2011.540233. Review.

PMID:
21219237
48.

A retrospective study of the incidence of diagnosed Type 1 diabetes among children and adolescents in a large health organization in Israel, 2000-2008.

Sella T, Shoshan A, Goren I, Shalev V, Blumenfeld O, Laron Z, Chodick G.

Diabet Med. 2011 Jan;28(1):48-53. doi: 10.1111/j.1464-5491.2010.03174.x.

PMID:
21166845
49.

Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne.

Ben-Amitai D, Laron Z.

J Eur Acad Dermatol Venereol. 2011 Aug;25(8):950-4. doi: 10.1111/j.1468-3083.2010.03896.x. Epub 2010 Nov 4.

PMID:
21054577
50.

Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor.

Yehezkel E, Weinstein D, Simon M, Sarfstein R, Laron Z, Werner H.

Diabetologia. 2010 Dec;53(12):2667-75. doi: 10.1007/s00125-010-1899-1. Epub 2010 Sep 12.

PMID:
20835859

Supplemental Content

Support Center